CPHI Global
CPHI Global, headquartered in China, is a leading player in the pharmaceutical and biotechnology industry, specialising in providing comprehensive solutions for drug development and manufacturing. Founded in 2000, the company has established a strong presence across major operational regions, including Asia, Europe, and North America. With a focus on contract manufacturing, active pharmaceutical ingredients (APIs), and excipients, CPHI Global distinguishes itself through its commitment to quality and innovation. The company has achieved significant milestones, including numerous partnerships with top-tier pharmaceutical firms, solidifying its market position as a trusted provider in the sector. CPHI Global continues to drive advancements in the industry, making it a pivotal player in the global pharmaceutical landscape.
DitchCarbon Score
How does CPHI Global's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CPHI Global's score of 20 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CPHI Global's reported carbon emissions
CPHI Global, headquartered in China (CN), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that CPHI Global has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of publicly available information on their climate commitments suggests that the company may still be in the early stages of developing a comprehensive sustainability strategy. As the pharmaceutical and biotechnology industries increasingly focus on reducing their carbon footprints, CPHI Global's future commitments and actions will be crucial in aligning with industry standards and addressing climate change effectively.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CPHI Global is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
